A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine

Get answers to your Genitourinary cancer questions.
Dr. Heather Mannuel’s Bio | Q&A Archive
Penile cancer; Squamous cell cancer - penis
Treatment depends on the size and location of the tumor and how much it has spread.
In general, cancer treatment includes:
If the tumor is small and near the tip of the penis, surgery may be done to remove only the cancerous part of the penis. This is called a partial penectomy.
For more severe tumors, total removal of the penis (total penectomy) is often necessary. A new opening will be created in the groin area to allow urine to exit the body. This procedure is called a urethrostomy.
Chemotherapy may be used along with surgery. Bleomycin, cisplatin, or methotrexate alone or together are usually used for treating penile cancer.
Radiation therapy is often recommended in combination with surgery. A type of radiation therapy called external beam therapy is often used. This method delivers radiation to the penis from outside the body. External beam radiation therapy is usually performed 5 days a week for 6 - 8 weeks.
Joining a support group where members share common experiences and problems may help relieve the stress associated with diagnosis and treatment of penile cancer.
The outcome can be good with early diagnosis and treatment. The 5-year survival rate for penile cancers is 65%. Urination and sexual function can often be maintained even when a significant portion of the penis is removed.
Cancer of the penis frequently spreads to other parts of the body (metastasizes) early in the course of the disease.
Call your health care provider if symptoms of penis cancer develop.
Pettaway CA, Lynch DF, Davis JW. Tumors of the penis. In: Wein AJ, ed. Campbell-Walsh Urology. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 31.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885